BioMarin Pharmaceutical Inc. (BMRN) Nasdaq Global Select
97.690.180.18%
CloseJanuary 18, 2019

News: updated – 18-Jan 11:46


Don’t Buy Codexis For The Long Haul18-Jan 12:32(SeekingAlpha)

Overview Codexis, Inc. ( CDXS ) relies on its CodeEvolver platform to manufacture and design proteins with specific properties in manufacturing, food production, biotech, and the like. Recently, Codexis has been given approval to continue work with CDX-6114, a prospective treatment for phe…